Johnson & Johnson Restructure: What Employees Need to Know

At the time of writing, Johnson & Johnson’s medtech division is undergoing another major restructuring, which is not uncommon for large global corporations navigating market changes. But regardless of current events, understanding your remuneration package matters whenever your circumstances change.

If you work at J&J, or know someone who does, this is about being prepared. We’ve helped numerous Johnson & Johnson executives navigate these transitions, from CEOs, MDs, VPs, to senior managers, and we know exactly what you’re facing.

Why This Matters (Even If You’re Not Being Made Redundant)

Johnson & Johnson is an exceptional company to work for. The benefits are generous: company-paid insurances, voluntary super contributions well above the standard, competitive salaries, and significant stock allocations. It’s why so many talented professionals stay for decades.

But whenever large-scale restructures happen, like the Kenvue spin-out two years ago, things change. Even if your role is secure, understanding how your remuneration package works becomes critical. And if redundancy is on the horizon, knowing your options early makes all the difference.

The Redundancy Payment: More Flexible Than You Think

Your redundancy payment is calculated based on years of service and salary. Here’s what most people don’t realise: it’s negotiable.

This isn’t a take-it-or-leave-it offer. From the actual cash amount to keeping your laptop, these conversations have room for movement. We’ve seen clients successfully negotiate better outcomes simply by asking.

The payment also receives concessional tax treatment. It’s not treated as normal income. Part of it comes through tax-free, part is taxed at 30%, and amounts above a certain threshold are taxed at your marginal rate. Understanding what you’ll actually receive after tax is essential for planning your next steps.

The key question is: Are you transitioning to retirement, or looking for your next role? Your answer changes everything about how you should handle this payment.

Your Russell Super: Critical Decisions Ahead

If You Have a Defined Benefit

For long-serving staff, your defined benefit is a significant asset. Potentially worth $1.5 million to $2 million or more. It’s calculated on your years of service and final salary, with Russell carrying all the investment risk.

Here’s the catch: when you leave Johnson & Johnson, your defined benefit converts to cash.

You then need to decide how to invest it. Conservative? Balanced? High growth? Or do you roll it into a self-managed super fund or industry fund? These aren’t decisions to make hastily, and sitting in cash (the default position) means your money earns virtually nothing.

If You Have an Accumulation Account

Even standard accumulation members face changes. You move from J&J’s corporate Russell offering into their public fund. This typically means:

• Higher fees
• Loss of corporate benefits
• You’re now responsible for all investment decisions

Insurance: Don’t Let It Slip Through

Johnson & Johnson generally pays your life, TPD, and income protection premiums, a valuable perk that ends when you leave.

You can continue your insurance through Russell, but you’ll now pay the premiums from your super. This is your moment to review:

• Is your cover still appropriate?
• Has your financial situation changed (paid off debt, kids through school)?
• Are you adequately protected if you’re between roles for six months?
• Is Russell’s insurance quality competitive with other providers?

Most people ignore this step. Don’t be like most people.

The Stock Situation: Age 55 Is Important

Johnson & Johnson’s stock structure is complex. You can elect RSUs (Restricted Stock Units) or Options, and senior executives also receive PSUs (Performance Stock Units). All vest over three years: 33% after year one, 66% after year two, 100% after year three.

If you’re 55 or older: You generally keep all unvested stock.

If you’re under 55: You lose any unvested stock allocations.

This is the golden handcuff. If you’re 54 with two years of unvested stock worth $300,000, that’s gone. If you’re 56 in the same situation, you keep it. One year makes an enormous difference.

What We’ve Seen Work

Over the years, we’ve guided J&J executives through:

• Maximising redundancy negotiations
• Strategic superannuation decisions (especially with defined benefits)
• Insurance restructuring
• Stock liquidation timing
• Transition planning—whether to retirement or a new role

The biggest mistakes we see:

1. Accepting the first redundancy offer without question
2. Leaving super in cash “to think about later”
3. Letting insurance lapse without reviewing needs
4. Not understanding stock vesting rules
5. Making emotional decisions without a clear financial plan

Your Next Steps

Whether redundancy is definite, possible, or just a concern you’re monitoring, having a plan matters. Your J&J benefits package is sophisticated. Significantly more complex than a straightforward salary role, and getting it wrong is costly.

The conversations you need to have now:

• What’s the real net value of your redundancy after tax?
• Where should your super be invested (or should it move elsewhere)?
• Is your insurance appropriate for your new circumstances?
• What happens to your unvested stock?
• If you’re looking for another role, what remuneration structure do you need to match what you’re leaving?
• If you’re retiring, how do we create an income stream that maintains your lifestyle?

We’ve worked with enough Johnson & Johnson executives to understand the nuances. The Russell Super quirks, the stock vesting rules, and the insurance transitions. This is our territory. If you’d like to discuss your specific situation, get in touch. Whether redundancy is confirmed or you’re simply preparing for what might happen, we’re here to help you navigate it with clarity and confidence.